Ahmed Abdulla Deemas Alsuwaidi serves as Executive at CALYPTE BIOMEDICAL CORP, where they oversee executive responsibilities. Since joining the company, Ahmed Abdulla Deemas Alsuwaidi has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jul 21, 2008 involved exercising options for 9,920,000 shares valued at $496.0K.
Ahmed Abdulla Deemas Alsuwaidi currently holds 33,920,000 shares of CALYPTE BIOMEDICAL CORP (CBMC.OB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Ahmed Abdulla Deemas Alsuwaidi has been a net neutral trader of CBMC.OB stock. They have purchased $0 and sold $0 worth of shares.
Ahmed Abdulla Deemas Alsuwaidi's most recent insider trade was on Jul 21, 2008, when they sold 9,920,000 shares at $0.05 per share.
Get notified when new Form 4 filings are submitted
| 4,000,000 |
| $0.08 |
| Discretionary |